These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35575500)

  • 1. Monoclonal Antibodies and Flaviviruses: a Possible Option?
    Mancini N
    mBio; 2022 Jun; 13(3):e0082422. PubMed ID: 35575500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.
    Doyle MP; Genualdi JR; Bailey AL; Kose N; Gainza C; Rodriguez J; Reeder KM; Nelson CA; Jethva PN; Sutton RE; Bombardi RG; Gross ML; Julander JG; Fremont DH; Diamond MS; Crowe JE
    mBio; 2022 Jun; 13(3):e0051222. PubMed ID: 35420472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.
    Ricciardi MJ; Rust LN; Pedreño-Lopez N; Yusova S; Biswas S; Webb GM; Gonzalez-Nieto L; Voigt TB; Louw JJ; Laurino FD; DiBello JR; Raué HP; Barber-Axthelm AM; Chun K; Uttke S; Raphael LMS; Yrizarry-Medina A; Rosen BC; Agnor R; Gao L; Labriola C; Axthelm M; Smedley J; Julander JG; Bonaldo MC; Walker LM; Messaoudi I; Slifka MK; Burton DR; Kallas EG; Sacha JB; Watkins DI; Burwitz BJ
    Sci Transl Med; 2023 Mar; 15(689):eade5795. PubMed ID: 36989376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope.
    Lu X; Xiao H; Li S; Pang X; Song J; Liu S; Cheng H; Li Y; Wang X; Huang C; Guo T; Ter Meulen J; Daffis S; Yan J; Dai L; Rao Z; Klenk HD; Qi J; Shi Y; Gao GF
    Cell Rep; 2019 Jan; 26(2):438-446.e5. PubMed ID: 30625326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
    Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
    Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
    Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialized
    Li D; Lu HT; Ding YZ; Wang HJ; Ye JL; Qin CF; Liu ZY
    J Virol; 2023 Apr; 97(4):e0194922. PubMed ID: 37017533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
    Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
    Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.
    Miorin L; Laurent-Rolle M; Pisanelli G; Co PH; Albrecht RA; García-Sastre A; Morrison J
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of flavivirus VLPs by a two-step chomatographic process.
    Lima TM; Souza MO; Castilho LR
    Vaccine; 2019 Nov; 37(47):7061-7069. PubMed ID: 31201056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles.
    Lücke AC; Vom Hemdt A; Wieseler J; Fischer C; Feldmann M; Rothenfusser S; Drexler JF; Kümmerer BM
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.
    Thibodeaux BA; Garbino NC; Liss NM; Piper J; Schlesinger JJ; Blair CD; Roehrig JT
    Antiviral Res; 2012 Apr; 94(1):1-8. PubMed ID: 22366350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
    Sandberg JT; Ols S; Löfling M; Varnaitė R; Lindgren G; Nilsson O; Rombo L; Kalén M; Loré K; Blom K; Ljunggren HG
    J Immunol; 2021 Aug; 207(4):1033-1043. PubMed ID: 34321231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
    Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.
    Kwallah Ao; Inoue S; Thairu-Muigai AW; Kuttoh N; Morita K; Mwau M
    Jpn J Infect Dis; 2015; 68(3):230-4. PubMed ID: 25672346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
    Reis LR; Costa-Rocha IAD; Campi-Azevedo AC; Peruhype-Magalhães V; Coelho-Dos-Reis JG; Costa-Pereira C; Otta DA; Freire LC; Lima SMB; Azevedo AS; Schwarcz WD; Ano Bom APD; Silva AMVD; Souza AF; Castro TDM; Ferroco CLV; Filippis AMB; Nogueira FB; Homma A; Domingues CM; Sousa ESS; Camacho LAB; Maia MLS; Teixeira-Carvalho A; Martins-Filho OA
    Vaccine; 2022 Jan; 40(5):798-810. PubMed ID: 34969545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein.
    Deng YQ; Dai JX; Ji GH; Jiang T; Wang HJ; Yang HO; Tan WL; Liu R; Yu M; Ge BX; Zhu QY; Qin ED; Guo YJ; Qin CF
    PLoS One; 2011 Jan; 6(1):e16059. PubMed ID: 21264311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serological cross-reactivity between yellow fever and other flaviviruses.
    Souza NCSE; Félix AC; de Paula AV; Levi JE; Pannuti CS; Romano CM
    Int J Infect Dis; 2019 Apr; 81():4-5. PubMed ID: 30660799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.